MANGOCEUTICALS, INC. Files 8-K: Material Agreement & Financials
Ticker: MGRX · Form: 8-K · Filed: Jul 11, 2024 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financials, corporate-action
Related Tickers: MANG
TL;DR
MANGOCEUTICALS (MANG) filed an 8-K on 7/11, reporting a material agreement and financials from 7/9.
AI Summary
On July 9, 2024, MANGOCEUTICALS, INC. entered into a material definitive agreement. The company also reported other events and filed financial statements and exhibits. The filing was made on July 11, 2024.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and the submission of financial documents, which could impact investor understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: medium — The filing of a material definitive agreement and financial statements suggests significant corporate actions that could carry inherent risks and opportunities for investors.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- July 9, 2024 (date) — Date of Earliest Event Reported
- July 11, 2024 (date) — Filing Date
- 15110 N. Dallas Parkway , Suite 600 Dallas , Texas 75248 (address) — Principal Executive Offices
- (214) 242-9619 (phone_number) — Registrant's telephone number
FAQ
What type of material definitive agreement did MANGOCEUTICALS, INC. enter into?
The filing states that MANGOCEUTICALS, INC. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 9, 2024.
What is the principal executive office address for MANGOCEUTICALS, INC.?
The principal executive office address for MANGOCEUTICALS, INC. is 15110 N. Dallas Parkway, Suite 600, Dallas, Texas 75248.
What is the SEC file number for MANGOCEUTICALS, INC.?
The SEC file number for MANGOCEUTICALS, INC. is 001-41615.
What is the IRS Employer Identification Number for MANGOCEUTICALS, INC.?
The IRS Employer Identification Number for MANGOCEUTICALS, INC. is 87-3841292.
Filing Stats: 808 words · 3 min read · ~3 pages · Grade level 11.6 · Accepted 2024-07-11 08:15:22
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 Par Value Per Share MGRX The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 131KB
- ex99-1.htm (EX-99.1) — 24KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- ex99-1_002.jpg (GRAPHIC) — 44KB
- ex99-1_003.jpg (GRAPHIC) — 24KB
- ex99-1_004.jpg (GRAPHIC) — 34KB
- 0001493152-24-026887.txt ( ) — 542KB
- mgrx-20240709.xsd (EX-101.SCH) — 3KB
- mgrx-20240709_lab.xml (EX-101.LAB) — 33KB
- mgrx-20240709_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MANGOCEUTICALS, INC. Date: July 11, 2024 By: /s/ Jacob D. Cohen Jacob D. Cohen Chief Executive Officer